metastatic/advanced UC (mUC) - 1st Line (L1) | ||
mUC - L1 - all population | mUC - L1 - PDL1 positive | |
Immune checkpoint association | ||
durvalumab plus tremelimumab | DANUBE ... | DANUBE ... |
Study type:
delta: difference in rate or median (if available)
- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy -